What this case supports, and what it does not

The evidence supports a specific, narrow claim set: positive identification requires reconciling independent sources rather than trusting any one of them, tourniquet time and tube handling relate to hemolysis risk in the reviewed evidence, the CLSI order of draw reduces additive carryover, and immediate bedside labeling keeps the patient, the specimen, and the record connected through handoff. It does not support a universal needle angle, an exact inversion count, a fixed number of attempts, a complete list of prohibited sites, or a specific postcollection observation time; those are set by manufacturer labeling, local procedure, and supervised competency, and they vary by organization and jurisdiction.

The one-minute tourniquet figure comes from a synthesis of published evidence linking longer application to more in-vitro hemolysis; it is a practical target for specimen quality, not a hard safety cutoff, and a single collection's duration does not by itself prove or disprove why any one specimen hemolyzed. The specimen collection manual that actually governs a given laboratory's collection practice is the laboratory's own current document, not a generic summary; CAP requires that manual to define patient identification, preparation, specimen collection and labeling, preservation, and transport and storage methods.

Independent practice on a real patient requires supervised competency in this organization's procedure.

Identification, timing, order, and the willingness to stop are the four levers a collector actually controls, and controlling all four is what makes a specimen trustworthy before it ever reaches an analyzer.